Esther Van Den Boom's Insider Trades & SAST Disclosures

Esther Van Den Boom's most recent trade in Tyra Biosciences Inc was a trade of 1,452 Common Stock done at an average price of $7.7 . Disclosure was reported to the exchange on Sept. 15, 2022.

Share

Note

This is a custom search result for pattern Esther Van Den Boom.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Tyra Biosciences Inc	Esther Van Den Boom	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 7.66 per share.	15 Sep 2022	1,452	121,897	-	7.7	11,120	Common Stock
Tyra Biosciences Inc	Esther Van Den Boom	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Sep 2022	105,000	105,000	-		-	Stock Option (Right to Buy)
Tyra Biosciences Inc	Esther Van Den Boom	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Sep 2022	89,054	89,054	-		-	Stock Option (Right to Buy)
Tyra Biosciences Inc	Esther Van Den Boom	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 8.53 per share.	06 Sep 2022	1,800	120,445	-	8.5	15,346	Common Stock
Tyra Biosciences Inc	Esther Van Den Boom	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Nov 2021	83,626	83,626	-		-	Stock Option (Right to Buy)
Tyra Biosciences Inc	Esther Van Den Boom	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Nov 2021	7,964	7,964	-		-	Stock Option (Right to Buy)
Tyra Biosciences Inc	Esther Van Den Boom	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Nov 2021	7,964	7,964	-		-	Stock Option (Right to Buy)
Tyra Biosciences Inc	Esther Van Den Boom	Chief Financial Officer		17 Sep 2021	21,254	21,254	-		-	Common Stock
Tyra Biosciences Inc	Esther Van Den Boom	Chief Financial Officer		17 Sep 2021	8,183	0	-		-	Series A Preferred Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades